Validity and Reliability of the U.S. National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

IMPORTANCE: Symptomatic adverse events (AEs) in cancer trials are currently reported by clinicians using the National Cancer Institute's (NCI) Common Terminology Criteria for Adverse Events (CTCAE). To integrate the patient perspective, the NCI developed a patient-reported outcomes version of t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Main Authors: Dueck, Amylou C., Mendoza, Tito R., Mitchell, Sandra A., Reeve, Bryce B., Castro, Kathleen M., Rogak, Lauren J., Atkinson, Thomas M., Bennett, Antonia V., Denicoff, Andrea M., O'Mara, Ann M., Li, Yuelin, Clauser, Steven B., Bryant, Donna M., Bearden, James D., Gillis, Theresa A., Harness, Jay K., Siegel, Robert D., Paul, Diane B., Cleeland, Charles S., Schrag, Deborah, Sloan, Jeff A., Abernethy, Amy P., Bruner, Deborah W., Minasian, Lori M., Basch, Ethan
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857599/
https://ncbi.nlm.nih.gov/pubmed/26270597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2015.2639
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares